TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Orion Pharma A/S
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
381,655
|
303,174
|
285,043 |
Earnings before taxes |
16,562
|
13,905
|
8,175 |
Total assets |
135,209
|
117,617
|
116,254 |
Current assets |
134,904
|
117,431
|
116,030 |
Current liabilities |
57,256
|
46,199
|
51,979 |
Equity capital |
77,952
|
71,418
|
64,275 |
- share capital |
4,525
|
4,247
|
4,024 |
Employees (average) |
35
![]() |
35
![]() |
35 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
57.7%
|
60.7%
|
55.3% |
Turnover per employee |
10,904
|
8,662
|
8,144 |
Profit as a percentage of turnover |
4.3%
|
4.6%
|
2.9% |
Return on assets (ROA) | |||
Current ratio |
235.6%
|
254.2%
|
223.2% |
Return on equity (ROE) |
21.2%
|
19.5%
|
12.7% |
Change turnover |
58,632
|
2,329
|
-94,335 |
Change turnover % |
18%
|
1%
|
-25% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.